Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    23728174 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
Condition: Parkinson's Disease
Intervention: Drug: Exenatide
2 Recruiting Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
Conditions: Dysglycemia;   Cognitive Deficit
Interventions: Drug: Exenatide;   Other: placebo

Study has passed its completion date and status has not been verified in more than two years.